Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta)-Reference-Cited by-同舟云学术

Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta)

Published:2021-12-03 Issue:49 Volume:7 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Trimpert Jakob¹^ORCID,Adler Julia M.¹²^ORCID,Eschke Kathrin¹,Abdelgawad Azza¹,Firsching Theresa C.³^ORCID,Ebert Nadine⁴⁵,Thao Tran Thi Nhu⁴⁵⁶,Gruber Achim D.³^ORCID,Thiel Volker⁴⁵^ORCID,Osterrieder Nikolaus¹⁷^ORCID,Kunec Dusan¹^ORCID

Affiliation:

1. Institut für Virologie, Freie Universität Berlin, Berlin, Germany.

2. Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.

3. Institut für Tierpathologie, Freie Universität Berlin, Berlin, Germany.

4. Institute of Virology and Immunology, Bern and Mittelhäusern, Switzerland.

5. Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.

6. Graduate School for Biomedical Science, University of Bern, Bern, Switzerland.

7. Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong.

Abstract

A single intranasal vaccination with live attenuated virus provides protection against VOC B.1.1.7 (Alpha) and B.1.351 (Beta).

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference42 articles.

1. World Health Organization Draft landscape of COVID-19 candidate vaccines (2021); https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.

2. Medicines and Healthcare products Regulatory Agency UK medicines regulator gives approval for first UK COVID-19 vaccine (2020); https://www.gov.uk/government/news/uk-medicines-regulator-gives-approval-for-first-uk-covid-19-vaccine.

3. FDA FDA takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 vaccine (2020); https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19.

4. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

5. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The rational design of mRNA vaccine: From empirical method to artificial intelligence-based design;Chinese Science Bulletin;2024-09-01

2. Single-cell-resolved interspecies comparison shows a shared inflammatory axis and a dominant neutrophil-endothelial program in severe COVID-19;Cell Reports;2024-06

3. Single intranasal immunization with attenuated Wuhan-like SARS-CoV-2 provides highly effective cross-protection against Delta and Omicron variants of concern;Journal of microbiology, epidemiology and immunobiology;2024-03-13

4. An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission;Nature Communications;2024-02-02

5. Marine natural products and human immunity: novel biomedical resources for anti-infection of SARS-CoV-2 and related cardiovascular disease;Natural Products and Bioprospecting;2024-01-29